$251,500 in grant funding distributed to 15 agencies
Fifteen nonprofit organizations serving 19 Western Slope counties received a total of $251,500 in the second quarter of 2018 grant awards from the Rocky Mountain Health Foundation.
The funding supports health- and wellness-related causes that directly affect education, prevention and access to health, community engagement, intervention and treatment.
Local quarterly recipients include: Doors 2 Success in Grand Junction; Family Visitor Program of Garfield County Inc., in Glenwood Springs; Girls on the Run in Grand Junction; the Joseph Center in Grand Junction; Strive in Grand Junction; Midwestern Colorado Mental Health Center in Montrose; Montrose Memorial Hospital in Montrose; Reach Out and Read Colorado in Grand Junction; the Riverside Educational Center in Grand Junction; and St. Mary's Medical Center Foundation in Grand Junction.
Rocky Mountain Health Foundation received requests for $750,710 from 26 agencies for the second quarter. It is anticipated that $1 million will be distributed in 2018 throughout quarterly grant awards.
Proposals for the next funding cycle are due by July 18. Prospective grant applicants can get in touch with grant manager Kim Lewis at 970-697-1038 or firstname.lastname@example.org. For information, visit rmhealth.org.
Tonsillectomy risks may outweigh benefits
More than 530,000 children have their tonsils or adenoids removed in the United States each year to prevent recurrent infections and sleep or breathing disorders. But a new study suggests the surgery may have long-term risks that in some cases outweigh any short-time benefits.
The report, in JAMA Otolaryngology — Head and Neck Surgery, compared 60,667 Danish children under 9 who had tonsillectomies, adenoidectomies or both with 1.1 million who had not had the surgeries. They were born between 1979 and 1999, and researchers followed their health for up to 30 years.
After controlling for many health factors, they found that tonsillectomy was associated with almost triple the relative risk of diseases of the upper respiratory tract. Adenoidectomy was associated with about double the relative risk of obstructive pulmonary disorder, upper respiratory tract diseases and conjunctivitis.
The surgery has some short-term benefits in cases of abnormal breathing, sinusitis and ear infections, but the long-term risks for those conditions were either significantly higher after surgery or not significantly different.
"This is the first study to look at long-term risks," said the lead author, Sean G. Byars, a research fellow at the University of Melbourne. "With some kids, knowing that there are future risks may cause people to hold off, use pain medication and so on. Watchful waiting may be a good strategy when the condition is not too severe."
First generic film strip of addiction drug cleared
The Food and Drug Administration approved a generic version of Suboxone, a film strip that dissolves under the tongue. Used daily, it reduces withdrawal symptoms, cravings for opioids and the high from abusing them.
The medication combines buprenorphine and naloxone. It's used along with counseling and other behavioral therapy.
The generic version will be sold by partners Mylan N.V. and Dr. Reddy's Laboratories SA. They didn't immediately respond to questions about when their version will be available or what it will cost.
Brand-name Suboxone film costs about $200 a month without insurance.
The FDA said the approval was aimed at making the treatment available to more people.